Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Centurion Acquisition | ALFUU | Nov 27, 2024 | 10.13 | +0.20 |
Century Aluminium | CENX | Nov 27, 2024 | 23.04 | -3.36 |
Century Casinos | CNTY | Nov 27, 2024 | 4.47 | -4.08 |
Century Communities | CCS | Nov 27, 2024 | 90.80 | -0.34 |
Century Therapeutics | IPSC | Nov 27, 2024 | 1.63 | +20.74 |
Cepton | CPTN | Nov 27, 2024 | 3.13 | 0.00 |
Ceragon Networks | CRNT | Nov 27, 2024 | 4.07 | -1.21 |
Cerence | CRNC | Nov 27, 2024 | 6.69 | +3.40 |
CeriBell | CBLL | Nov 27, 2024 | 28.84 | 0.00 |
CERo Therapeutics | CERO | Nov 27, 2024 | 0.20 | +37.62 |
Certara | CERT | Nov 27, 2024 | 11.27 | +3.11 |
Cerus | CERS | Nov 27, 2024 | 1.82 | +3.41 |
CervoMed | CRVO | Nov 27, 2024 | 9.15 | +14.72 |
CEVA | CEVA | Nov 27, 2024 | 29.15 | -1.09 |
CF Acquisition VII A | CFFS | Nov 27, 2024 | 11.21 | 0.00 |
CF Bankshares | CFBK | Nov 27, 2024 | 28.00 | +0.72 |
CF Industries | CF | Nov 27, 2024 | 88.66 | +0.59 |
CFSB Bancorp | CFSB | Nov 27, 2024 | 6.68 | -0.32 |
CG Oncology | CGON | Nov 27, 2024 | 34.10 | +0.59 |
CGI | GIB | Nov 27, 2024 | 112.59 | +0.78 |
Chain Bridge Bancorp | CBNA | Nov 27, 2024 | 24.20 | 0.00 |
Chain Bridge I SPAC A | CBRG | Nov 27, 2024 | 11.49 | 0.00 |
Chain Bridge I Units | CBRGU | Nov 27, 2024 | 11.26 | 0.00 |
Champion Homes | SKY | Nov 27, 2024 | 103.73 | +0.27 |
Champions Oncology | CSBR | Nov 27, 2024 | 4.31 | -0.46 |
ChampionX | CHX | Nov 27, 2024 | 30.70 | +0.52 |
Channel Therapeutics | CHRO | Nov 27, 2024 | 0.63 | +4.53 |
Chanson International | CHSN | Nov 27, 2024 | 7.25 | +1.97 |
ChargePoint | CHPT | Nov 27, 2024 | 1.17 | +1.74 |
Charles & Colvard | CTHR | Nov 27, 2024 | 1.28 | -1.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.